NCT01266759

Efficacy of Combined Contraceptive Vaginal Ring(NuvaRing)in Women With Idiopathic Menorrhagia

Combined Contraceptive Vaginal Ring or Norethisterone for Treatment of Idiopathic Menorrhagia

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 95 (actual)
• Sponsor: Mansoura University · Academic / Other
• Sex: Female
• Age: 20 Years – 35 Years
• Healthy volunteers: Not accepted

Summary

To compare the efficacy of a combined contraceptive vaginal ring (NuvaRing) and oral Norethisterone Acetate in treatment of Idiopathic heavy menstrual bleeding during fertile age

Conditions

• Menorrhagia

Interventions

Type	Name	Description
DRUG	NuvaRing	For the first cycle, women inserted the ring between days 1 and 5 of the menstrual cycle. Treatment continued for three cycles. Each cycle consisted of 3 weeks of ring use followed by a 1 week ring-free period.
DRUG	Norethisterone Acetate tablets - 5mg	Norethisterone Acetate tablets 5 mg three times daily from day 5 to 26 of the cycle over three cycles. Male condom used for contraception during treatment

Timeline

• Start date: 2008-07-01
• Primary completion: 2010-09-01
• Completion: 2010-09-01
• First posted: 2010-12-24
• Last updated: 2010-12-24

Locations

1 site across 1 country: Egypt